Bisan-Di Tablet
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Aprogen Biologics, Co., Ltd.
MFDS item code 201904464 · Approved 2019.06.28
This product's status changed to Approval withdrawn on 2024.03.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (including ulcers and gastritis); prevention of Mendelson syndrome
This medicine is used to treat ulcers that occur in the stomach and duodenum, gastritis, and conditions such as Zollinger-Ellison syndrome. It also alleviates the symptoms of gastroesophageal reflux disease and is used to prevent Mendelson's syndrome when administered before anesthesia. It is effective in the prevention and treatment of ulcers that may occur post-operation, and it is also used for gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs). This medication is helpful for various gastrointestinal diseases, protects the gastric mucosa, and improves symptoms.
○ Adults Usually, administer 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 2 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet twice daily for 8 weeks or 2 tablets once daily at bedtime. In patients with severe reflux esophagitis, the dose may be increased to 2 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. It is also preferable to administer 1 tablet on the evening before surgery.
This medication should not be administered to patients with impaired kidney function or those undergoing dialysis. Individuals who have shown allergic reactions to this drug or its components should not use it. Caution should be exercised in patients with a history of rare disorders such as acute porphyria, as this drug may exacerbate symptoms. This medication is also not recommended for patients who have undergone upper gastrointestinal surgery, pregnant women, or neonates and premature infants. Patients following a potassium-restricted diet should also avoid this medication. Careful administration is required in patients with compromised liver function, those with a history of drug allergies, elderly patients, and patients with renal impairment. When taken in conjunction with non-steroidal anti-inflammatory drugs, special caution is necessary and regular observation by a physician is required. This medication may conceal symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who have recently experienced new or changed indigestion symptoms should confirm the absence of malignant diseases before use. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require bacterial eradication therapy. Special caution is necessary for severely ill patients in intensive care, patients with hypophosphatemia, and patients with swallowing difficulties. If symptoms such as shock, severe allergic reactions, skin rashes, urticaria, or respiratory distress occur while taking this medication, it should be discontinued immediately and medical consultation sought. Blood tests may reveal leukopenia, thrombocytopenia, or liver function abnormalities, so if abnormal symptoms arise, the hospital should be informed immediately. Neurological symptoms such as dizziness, drowsiness, confusion, and seizures may also occur, though rarely, so careful observation is required. It is safest for pregnant women and nursing mothers not to take this medication, and it is not recommended for children as safety and efficacy have not been established. This medication should not be used for long periods, and if it does not have a therapeutic effect, alternative medications should be considered. If dizziness or drowsiness is experienced while taking this medication, driving or operating dangerous machinery should be avoided. Interactions with other medications may occur, so if other medications are being taken, it is essential to inform the physician or pharmacist, particularly regarding adjustments needed when taking anticoagulants or certain antibiotics. In cases of overdose, emergency measures such as inducing vomiting or gastric lavage may be necessary, and in some cases, blood dialysis may be required. Lastly, this medication reduces gastric acid secretion, which may promote bacterial growth in the stomach, so regular check-ups, including eye examinations, are recommended during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's effectiveness and safety over time.
Greenish rectangular film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Tripotassium Bismuth Dicitrate 200mg · Ranitidine Hydrochloride 168mg +1 more
Tablet · Prescription medication · Combination
Aprogen Biologics, Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.